Vertex Pharmaceuticals Inc
VRTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2012 | Q3 2011 | Q3 2010 | Q3 2009 |
|---|---|---|---|---|
| Revenue | $336.01M | $659.20M | $23.80M | $24.96M |
| Net Income | -$57.54M | $221.11M | -$208.96M | -$149.57M |
| EPS Diluted | -$0.27 |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| $1.02 |
| -$1.04 |
| -$0.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.